Eocene (EOCN) vs PRF Technologies (PRFX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Eocene is the larger company by market cap ($1.9 million vs $1.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EOCN | PRFX |
|---|---|---|
| Share price | $1.78 | $0.4758 |
| Market cap | $1.90M | $1.66M |
| 1-day change | +1.73% | -23.68% |
| EPS (TTM) | $-15.21 | $-4.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $17.00K |
| Net income (latest FY) | $-10.31M | $-5.02M |
| Gross margin | — | -311.76% |
| Operating margin | — | -30129.41% |
| Net margin | — | -29541.18% |
| 52-week high | $10.08 | $7.95 |
| 52-week low | $1.75 | $0.46 |
| Distance from 52-week high | -82.34% | -94.02% |
| Analyst consensus | none | — |
| Average volume | 18.17K | 228.55K |
| Shares outstanding | 1.07M | 3.50M |
| Employees | 3 | 6 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Eocene
EOCN stock →Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About PRF Technologies
PRFX stock →PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
EOCN vs PRFX FAQ
Which is bigger, Eocene or PRF Technologies?
Eocene (EOCN) is larger, with a market capitalization of $1.90M compared with $1.66M for PRF Technologies (PRFX).
Are Eocene and PRF Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.